Updates from The Motley Fool

Latest updates on Compugen Ltd. (USA) from Fool.com.

Stock Performance

CGEN vs. S&P 500 | 2 Year Performance
CGEN 1-Day Stock Chart
CGEN 5-Day Stock Chart
CGEN 1-Month Stock Chart
CGEN 3-Month Stock Chart
CGEN 6-Month Stock Chart
CGEN 1-Year Stock Chart
CGEN 2-Year Stock Chart
CGEN 5-Year Stock Chart
View Interactive CGEN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Compugen Ltd. (USA).
Current Price: $6.88
Prev Close: $6.78
Open: $6.73
Bid: $6.62
Ask: $7.29
Day's Range: $6.65 - $7.01
52wk Range: $4.32 - $7.98
Volume: 119,261
Avg Vol 101,777
Market Cap: $347.17M
P/E (ttm): -16.95
EPS (ttm): -$0.40
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Compugen Ltd. (USA).
CAPS Rating 5 out of 5
60 Outperform
4 Underperform
CAPS All Stars
2 Outperform
1 Underperform

How do you think Compugen Ltd. (USA) will perform against the market?

You pick for Compugen Ltd. (USA) is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Anat Cohen-Dayag, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Compugen Ltd. (USA).

A biotechnology discovery company focused on discovering and licensing of product candidates to the drug and diagnostic industry.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers